We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$163M
AUM Growth
+$37.9M
Cap. Flow
+$24.2M
Cap. Flow %
14.86%
Top 10 Hldgs %
53.54%
Holding
148
New
5
Increased
40
Reduced
5
Closed
95

Sector Composition

Rank Sector Weight
1 Healthcare 0.89%
2 Technology 0.89%
3 Financials 0.67%
4 Real Estate 0.02%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORTX
51
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$115K 0.07%
+1,913
New +$175K
ADAM
52
Adamas Trust
ADAM
$807M
$26K 0.02%
+2,500
New +$21.9K
PEI
53
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$14K 0.01%
+667
New +$12K
ABT icon
54
Abbott
ABT
$175B
-35
Closed -$2.76K
ADBE icon
55
Adobe
ADBE
$94.3B
-88
Closed -$28K
ADSK icon
56
Autodesk
ADSK
$46.1B
-632
Closed -$98.7K
AGG icon
57
iShares Core US Aggregate Bond ETF
AGG
$139B
-948
Closed -$109K
AKAM icon
58
Akamai
AKAM
$17.5B
-267
Closed -$24.4K
ALL icon
59
Allstate
ALL
$64.3B
-12
Closed -$1.1K
AMZN icon
60
Amazon
AMZN
$2.66T
-1,040
Closed -$101K
AXP icon
61
American Express
AXP
$242B
-16
Closed -$1.37K
BA icon
62
Boeing
BA
$169B
-215
Closed -$32.1K
BABA icon
63
Alibaba
BABA
$276B
-493
Closed -$95.9K
BBY icon
64
Best Buy
BBY
$18B
-17
Closed -$974
BFAM icon
65
Bright Horizons
BFAM
$4.03B
-8
Closed -$816
BIO icon
66
Bio-Rad Laboratories Class A
BIO
$8.15B
-6
Closed -$2.1K
BSX icon
67
Boston Scientific
BSX
$65.4B
-42
Closed -$1.37K
CDNS icon
68
Cadence Design Systems
CDNS
$91B
-19
Closed -$1.25K
CGC
69
Canopy Growth
CGC
$397M
-42
Closed -$6.04K
COF icon
70
Capital One
COF
$128B
-14
Closed -$709
CPB icon
71
Campbell Soup
CPB
$6.58B
-28
Closed -$1.29K
CRON
72
Cronos Group
CRON
$1.04B
-117
Closed -$663
CSGP icon
73
CoStar Group
CSGP
$12.2B
-420
Closed -$24.7K
CVS icon
74
CVS Health
CVS
$137B
-22
Closed -$1.3K
DAL icon
75
Delta Air Lines
DAL
$55.4B
-29
Closed -$827

Similar funds

Forefront Analytics's Q2 2020 Portfolio in Review

As of Q2 2020, Forefront Analytics held 148 positions worth $163M, up 30% from $125M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Forefront Analytics deployed $24.2M of net new capital in Q2 2020, opening 5 new positions and adding to 40 existing holdings. Its largest new stake was BioNTech: 3,536 shares worth $236K.

By sector, the portfolio is most concentrated in Healthcare at 0.89% of assets, up from 0.09% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ProShares Ultra Russell2000, an estimated $85.7K trimmed.

  • Forefront Analytics's largest Q2 2020 buy was BioNTech: 3,536 shares worth $236K.
  • Forefront Analytics added most to iShares Core High Dividend ETF in Q2 2020, an estimated $2.39M increase.
  • Forefront Analytics's biggest Q2 2020 reduction was ProShares Ultra Russell2000, cutting an estimated $85.7K.
  • Forefront Analytics fully exited ProShares UltraShort S&P500 in Q2 2020, selling an estimated $798K.
  • Forefront Analytics's ten largest holdings make up 54% of its $163M portfolio in Q2 2020.
  • Forefront Analytics opened 5 new positions and closed 95 in Q2 2020.
  • Forefront Analytics's portfolio value rose 30% quarter-over-quarter to $163M.

Based on Forefront Analytics's 13F filing for Q2 2020, filed 10 Aug 2020.